"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Having an episiotomy, a surgical cut to the vagina during childbirth, doubles the risk of postpartum hemorrhage (PPH) in women with moderate or severe anemia, according to new research published in ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

DUBLIN, IRELAND AND LONDON, UK = / ACCESS Newswire / December 8, 2025 / Ayrmid Ltd. ("Ayrmid" or the "Company"), the parent company of Gamida Cell Inc., a leader in cell therapy innovation today ...

The FDA has approved omidubicel-onlv (Omisirge, Gamida Cell Ltd.) as the first hematopoietic stem cell transplant therapy for patients with severe aplastic anemia (SAA). Specifically, omidubicel is ...

Though anemia is silent, it is preventable. It only requires early diagnosis, understanding the cause, education about proper ...

New data presented at the 2025 ASH demonstrates 94% disease free and overall survival rate Omisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic Anemia Key Highlights of Data ...

No cases of BMT-CTN severe acute graft-versus-host disease (GVHD), or chronic GVHD observed Omisirge approved by the FDA on December 5, 2025 for SAA DUBLIN, IRELAND AND LONDON, UK = / ACCESS Newswire ...